Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
06/2007
06/26/2007CA2209486C Preparation of 3,5-diarylpyrazoles
06/21/2007WO2007070398A1 Polycyclic indazole derivatives that are erk inhibitors
06/21/2007WO2007069771A1 Benzoylpyrazole compounds and herbicides containing them
06/21/2007WO2007068377A1 Carboxamides for controlling micro-organisms in plant and material protection
06/21/2007WO2007068376A1 Biphenyl carboxamides for controlling micro-organisms
06/21/2007WO2007068373A1 Carboxamides
06/21/2007US20070142381 Calcium receptor modulating agents
06/21/2007US20070142329 2-Chloro-N-[2-(2-chloro-phenyl)-ethyl]-5-(6-oxo-1,6-dihydro-pyrazin-3-yl)benzamide, for example; useful in the treatment of IL-1 mediated disorders, including inflammatory diseases such as osteoarthritis and rheumatoid arthritis, allergies, asthma, COPD, cancer
06/21/2007US20070142305 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; platelet-derived growth factor receptor (PDGF-R)
06/21/2007US20070142230 herbicides; act against broad-leaved weeds and grass weeds in crops such as wheat, rice, corn, soya and cotton without causing any significant damage to the crop plants
06/21/2007US20070142229 Agriculture
06/21/2007DE102005058418A1 Verfahren zur Herstellung von Haloalkyl(thio)vinimidiniumsalzen und 4-(Haloalkyl(thio))-pyrazolen und deren Umsetzung zu Pflanzenschutzmitteln Vinimidinium salts process for preparing haloalkyl (thio) and 4- (haloalkyl (thio)) - pyrazoles and their conversion into pesticides
06/21/2007CA2808259A1 Polymorphs and amorphous forms of 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1h-pyrazole-3-carbonitrile
06/21/2007CA2808257A1 Polymorphs and amorphous forms of 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1h-pyrazole-3-carbonitrile
06/21/2007CA2633192A1 Carboxamides for controlling micro-organisms in plant and material protection
06/21/2007CA2633190A1 Biphenyl carboxamides for controlling micro-organisms
06/21/2007CA2633023A1 Polycyclic indazole derivatives that are erk inhibitors
06/20/2007EP1797042A1 Indozolone derivatives as 11b-hsd1 inhibitors
06/20/2007EP1797041A2 Process for preparing bicyclic pyrazolyl compounds
06/20/2007EP1611094B1 Pyrazole compounds
06/20/2007EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/20/2007CN1984899A CXCR1 and CXCR2 chemokine antagonists
06/20/2007CN1984892A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
06/20/2007CN1984889A Organometallic complex, luminous solid, organic EL element and organic EL display
06/20/2007CN1982316A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
06/20/2007CN1321983C Pyrazole-containing semicarbazide compound and its preparation method and use
06/19/2007US7232912 For therapy of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
06/19/2007US7232836 1-(3-halopyrid-2-yl)-3-substituted-5-((2,4-substituted-6-aminocarbonyl)phenylaminocarbonyl) pyrazoles insecticides
06/19/2007US7232816 Phosphodiesterase inhibitors; used to treat inflammatory conditions, allergies such as rhinitis, respiratory system disorders and cancer
06/19/2007US7232792 3-heterocyclyl-substituted benzoyl derivatives
06/19/2007US7232616 Complex
06/14/2007WO2007067994A1 Inhibitors of histone deacetylase for the treatment of disease
06/14/2007WO2007067993A1 Inhibitors of histone deacetylase for the treatment of disease
06/14/2007WO2007067836A2 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors
06/14/2007WO2007067817A1 Abca1 elevating compounds
06/14/2007WO2007067814A2 Targeting gli proteins in human cancer by small molecules
06/14/2007WO2007065567A1 Process for preparing haloalkyl(thio)vinimidinium salts and 4-(haloalkyl(thio))pyrazoles and their conversion to crop protection agents
06/14/2007WO2007034183A3 Process for the preparation of 4-aminopyrazole derivatives
06/14/2007WO2007030582A3 Acyclic ikur inhibitors
06/14/2007WO2007017631A3 Process for printing an image, composition and compound
06/14/2007DE19849496B4 Nicht-flüchtige Alkylpyrazol-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als Nitrifikationsinhibitoren The non-volatile Alkylpyrazol derivatives, processes for their preparation and their use as nitrification inhibitors
06/14/2007DE10103565B4 Zusammensetzungen, enthaltend einen Ruthenium(III)-komplex und einen Heterocyclus Compositions comprising a ruthenium (III) complex and a heterocycle
06/14/2007CA2632813A1 Targeting gli proteins in human cancer by small molecules
06/14/2007CA2630233A1 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors
06/13/2007EP1795194A2 Use of an antagonist of CB1 receivers associated with a beta3-agonist for preparing medication to be used for treating appetence
06/13/2007EP1794131A2 A process for the preparation of 1,3,5-trisubstituted pyrazoles via ý3+2¨cycloaddition
06/13/2007EP1794130A1 Pyrazole compounds useful in the treatment of inflammation
06/13/2007EP1793828A2 Fibrate compounds having ppar agonist activity
06/13/2007EP1611122B1 Substituted pyrazole compounds
06/13/2007EP1330425B1 C-nitroso compounds and use thereof
06/13/2007EP1214292B1 Tyrosine derivatives
06/13/2007CN1980927A Pyrazolopyridine derivatives
06/13/2007CN1980918A Substituted indazoles, compositions containing the same, and the preparation and use thereof
06/13/2007CN1980892A Dpp-IV inhibitors
06/13/2007CN1980665A Pyrazole amide derivatives, compositions containing such compounds and methods of use
06/13/2007CN1980663A Prodrugs of mitotic kinesin inhibitors
06/13/2007CN1978443A Photochromic thiophene pyrazole heterocyclic mixed linkage type asymmetrical dithienylethene compounds, and their preparing method and use
06/13/2007CN1978432A Process for the preparation of phenyl pyrazole compounds
06/13/2007CN1321112C Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
06/13/2007CN1321101C New retinoids for the treatment of emphysema
06/12/2007US7230116 For use as pesticides, microbicides and herbicides
06/12/2007US7230025 Pyrazole derivatives
06/12/2007US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer
06/12/2007US7229988 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
06/12/2007CA2417264C Crystalline therapeutic agent
06/07/2007WO2007064273A1 Phenyl urea derivatives
06/07/2007WO2007063839A1 Cyclohexane derivative
06/07/2007WO2007062996A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
06/07/2007WO2007062790A2 Transition metal compound, ligand system, catalyst system and process for preparing polyolefins
06/07/2007WO2007062776A1 Method for producing 5-fluoro-1,3-dialkyl-1h-pyrazol-4-carboxylic acid chlorides
06/07/2007WO2007062678A1 Phenoxyacetic acid derivatives as crth2 receptor ligands
06/07/2007WO2007043677A9 Hydrazide compound and pesticidal use of the same
06/07/2007WO2007024744A3 Heterocyclic carboxamide compounds as steroid nuclear receptor ligands
06/07/2007WO2006062898A3 Compounds and methods for treating hemorrhagic fever viruses
06/07/2007US20070129539 Selective, tissue-specific TPO receptor agonists; thrombocytopenia resulting from radiation or chemotherapy; drug screening; [(N-substituted-2-oxo-1,2-dihydroindol-3-ylidene)hydrazino]-2-phenols; amyotrophic lateral sclerosis, multiple sclerosis, spinal cord injuries, muscular dystrophy
06/07/2007US20070129418 di-tert-butyl 4-{[1-(3,3-dimethyl-2-oxobutyl)-6-methoxy-1-H-indazole-3-yl]carbonyl}benzylphosphate; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, elevated intraoccular pressure in the eye
06/07/2007US20070129417 cannabinoid receptor modulators such as 1-cyclohexyl-4,5,6,7,8,9-hexahydro-1H-cyclooctapyrazole-3-carboxylic acid (adamantan-1-ylmethyl)-amide, used as dietetics, neuroprotectants, cognition activators, for treating diabetes, vision defects, psychological, respiratory system or gastrointestinal disorders
06/07/2007US20070129404 kinase enzyme inhibitor 5-[4-(1-amino-1-methylethyl)phenyl]-1H-indazole, useful as a drug treating eye diseases including glaucoma
06/07/2007US20070129374 1,2-dihydro-2-(4-trifluoromethylphenyl)-6-(3-trifluoromethyl-2-pyridinyl)-3H-indazol-3-one; capsaicin receptor ; analgesic, antiinflammatory, hypotensive agent; rheumatoid arthritis, osteoarthritis, headache, migraine, cancer and central nervous system pain, irritable bowel syndrome
06/07/2007US20070129369 Heteroaryl substituted cyclohexyl-1,4-diamine compounds
06/07/2007US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia
06/07/2007CA2629962A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
06/06/2007EP1792901A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
06/06/2007EP1791825A1 Benzoyl-substituted serine amides
06/06/2007EP1791819A1 (hetero)cyclyl(thio) carboxylic acid anilides for controlling pathogenic fungi
06/06/2007EP1791427A1 (hetero)cyclylcarboxamides for controlling pathogenic fungi
06/06/2007DE102005057180A1 Verfahren zum Herstellen von 5-fluor-1,3-dialkyl-1H-pyrazol-4-carbonsäurefluoriden A process for producing 5-fluoro-1,3-dialkyl-1H-pyrazole-4-carboxylic acid fluorides
06/06/2007CN1319974C Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
06/05/2007USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2
06/05/2007US7227032 3,3-dialkoxy-2-hydroxyiminopropionitriles, process for preparation thereof and process of preparing 5-amino-4-nitrosopyrazoles or salts thereof by the use of the same
06/05/2007US7227025 Halogenation and oxidation of a 5-carboxyl-3-oxo-1-aryl-substituted-1H-pyrazolidine
06/05/2007US7226950 Sodium channel modulators
06/05/2007US7226941 Compound for treating angiogenesis
06/05/2007US7226930 Phosphodiesterase 4 inhibitors
05/2007
05/31/2007WO2007060484A1 Azetidine derivatives as glyt1 inhibitors
05/31/2007WO2007060166A1 New n-phenethylcarboxamide derivatives
05/31/2007WO2007060164A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
05/31/2007WO2007060026A1 Urea derivatives useful as calcium receptor modulators
05/31/2007WO2005099688A3 Cyclic compounds
05/31/2007US20070123578 Hexahydro-cycloheptapyrazole cannabinoid modulators